From: MVDA: a multi-view genomic data integration methodology
Dataset | Response | N(0) | N(1) | N(2) | N(3) | Gene | RNASeq | microRNA | miRNASeq | Protein | Copy | Clinical |
---|---|---|---|---|---|---|---|---|---|---|---|---|
expression | expression | expression | number | data | ||||||||
Breast Cancer from The Cancer genome Atlas, N = 151 | ||||||||||||
TCGA.BRC | Pam50 (Her2,Basal,LumA,LumB) | 24 | 13 | 55 | 59 | x | x | |||||
Breast Cancer from The Gene Expression Omnibus, N = 201 | ||||||||||||
OXF.BRC.1 | Pam50 (Her2,Basal,LumA,LumB) | 26 | 6 | 117 | 52 | x | x | |||||
OXF.BRC.2 | Clinical (Level1, Level2, Level3, Level4) | 73 | 54 | 42 | 32 | x | x | |||||
Prostate Cancer from Memorial Sloan-Kettering Cancer Center, N = 88 | ||||||||||||
MSKCC.PRCA | Tumor stages T1 vs. T2, T3, T4 | 53 | 35 | x | x | x | x | |||||
Ovarian Cancer from The Cancer Genome Atlas, N = 398 | ||||||||||||
TCGA.OVG | Tumor stage I,II, Tumor stage III, Tumor stage IV | 33 | 315 | 50 | x | x | x | |||||
Glioblastoma Multiforme from The Cancer genome Atlas, N = 167 | ||||||||||||
from TCGA.GBM | (Classical, Mesechymal, Neural, Proneural) | 37 | 54 | 24 | 52 | x | x |